Physician profile
Eric J Lerman
NPI 1366432114
$414.99
in general payments reported to CMS, 2019-2025
10 companies · $20.32 in 2025
The $20.32 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $109 · 2021: $14.53 · 2022: $88.18 · 2023: $45.40 · 2025: $20.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ablative Solutions, INC. | $109.09 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.37 | 2022 | |
| Astellas Pharma US INC | $65.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $35.93 | 2019 | |
| Janssen Pharmaceuticals, INC | $31.34 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $30.78 | 2023 | Hetlioz |
| Pfizer INC. | $24.10 | 2019 | |
| Abbott Laboratories | $20.32 | 2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.62 | 2023 | Xifaxan |
| Lilly USA, LLC | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.